우선정 (차의과학대학교 분당차병원)님 | 한빛사연구자 > 한빛사

차의과학대학교 분당차병원

최종업데이트 2025.12.22.

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer
- Clin. Mol. Hepatol., Dec 26 2025, | https://doi.org/10.3350/cmh.2025.1019
- 2025-12
- 의약학
- 한빛사논문
Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study
- Hepatology, Dec 19 2025, | https://doi.org/10.1097/HEP.0000000000001650
- 2025-12
- 의약학
- 한빛사논문
Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular Features
- Clin. Mol. Hepatol., Oct 27 2025, | https://doi.org/10.3350/cmh.2025.0792
- 2025-10
- 의약학
- 한빛사논문
[Letter to the Editor] Reply to: Correspondence on ‘Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer’
- J. Hepatol., Available online 12 February 2025 | https://doi.org/10.1016/j.jhep.2025.02.006
- 2025-02
- 의약학
- 한빛사논문
Osteoblast-Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation
- Adv. Sci., Jan 31 2025, | https://doi.org/10.1002/advs.202412621
- 2025-01
- 바이오·의료융합
- 한빛사논문
Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer
- J. Hepatol., Available online 21 October 2024 | https://doi.org/10.1016/j.jhep.2024.10.020
- 2024-10
- 의약학
- 한빛사논문

연구자 ID

저자논문